NCT05865093 Early Visual Functions in Patients at Risk of Developing Cerebral Visual Impairment. A Pilot Study
| NCT ID | NCT05865093 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fondazione Policlinico Universitario Agostino Gemelli IRCCS |
| Condition | Visual Impairment |
| Study Type | OBSERVATIONAL |
| Enrollment | 700 participants |
| Start Date | 2022-07-01 |
| Primary Completion | 2023-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 700 participants in total. It began in 2022-07-01 with a primary completion date of 2023-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of the study is to assess visual function from neonatal age to 36 months of age in infants at risk of visual impairment due to brain lesion or ocular pathology
Eligibility Criteria
Inclusion Criteria: * Age between 34 weeks of post-menstrual age and 36 months of life in children born before 37 weeks gestational age * Genetic syndroms * Hypoxic Hischemic Encephalopathy * Brain malformation * Metabolic diseases * Ocular pathologies Exclusion Criteria: * Patients at low risk of developing neurological outcomes * Refusal of informed consent
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05865093 clinical trial?
This trial is open to participants of all sexes, aged 2 Days or older, up to 36 Months, studying Visual Impairment. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05865093 currently recruiting?
Yes, NCT05865093 is actively recruiting participants. Contact the research team at d.ricci@iapb.it for enrollment information.
Where is the NCT05865093 trial being conducted?
This trial is being conducted at Rome, Italy.
Who is sponsoring the NCT05865093 clinical trial?
NCT05865093 is sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS. The trial plans to enroll 700 participants.